Preventing Geriatric Oncology Patients from the Spread of COVID-19
Received Date : 20 May 2020
Accepted Date : 29 May 2020
Available Online : 18 Jun 2020
Doi: 10.37047/jos.2020-76410 - Article's Language: EN
J Oncol Sci.2020;6(2):131-2
This is an open access article under the CC BY-NC-ND license
  1. Ries EM, Kosary CL, Hankey BF, et al. SEER Cancer Statistics Review, 1975-2000. National Cancer Institute.
  2. D'Adamo H, Yoshikawa T, Ouslander JG. Coronavirus disease 2019 in geriatrics and long-term care: the ABCDs of COVID-19. J Am Geriatr Soc. 2020;68(5):912-917. [Crossref]  [PubMed] 
  3. Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335-337. [Crossref]  [PubMed] 
  4. Zhang L, Zhu F, Xie L, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020;31(7):894-901. [Crossref]  [PubMed]  [PMC] 
  5. El-Shakankery KH, Kefas J, Crusz SM. Caring for our cancer patients in the wake of COVID-19. Br J Cancer. 2020;123(1)3-4. [Crossref]  [PubMed]  [PMC] 
  6. You B, Ravaud A, Canivet A, et al. The official French guidelines to protect patients with cancer against SARS-CoV-2 infection. Lancet Oncol. 2020;21(5):619-621. [Crossref]  [PubMed] 
  7. Waisberg F, Enrico D, Angel M, Chacón M. Cancer treatment adaptations in the COVID-19 era. JCO Oncol Pract. 2020;16(6):305-307. [Crossref]  [PubMed]  [PMC]